Germline mutations in breast cancer susceptibility gene 1 (BRCA1) and/or breast cancer susceptibility gene 2 (BRCA2) confer an increased risk of breast and ovarian cancers [4]. This evidence concerns the gene BRCA2 and ovarian cancer.